When a critical component fails, having the right part can mean the difference between hours of downtime or weeks. Additive manufacturing (AM) is a transformative solution, rapidly producing complex s...
Data center development is running up against seven-year power queues, water scarcity, and regulatory resistance. Meanwhile, orbital compute has moved from concept to operational status, with recent G...
Agentic AI is at the planning and piloting stages in many enterprises, with few implementing it at scale. Its emergence coincides with growing recognition that AI initiatives often take longer than ex...
There is strong evidence that empathetic, yet tough, leadership achieves better long-term results than strict authoritarianism. Adhering to these principles is not so hard when things are going smooth...
AI is becoming a core infrastructure for the digital economy, while capital, valuations, and expectations accelerate at an unusual speed. For leaders, the challenge is straightforward but demanding: b...
AI and network APIs are moving swiftly from concept to reality, but they require an architecture with standard components, shared data, and predictable interfaces. Open digital architecture (ODA) prov...
Telco returns are under pressure from persistent CAPEX and slow growth. As financial sponsors increasingly own communication service providers (CSPs), they need a new operating model, one that drives ...
Private equity (PE) firms are geared toward accelerating growth and enhancing the value of their investments. Yet the intense focus on results, efficiency, and cost-cutting can comparatively depriorit...
A wave of optimism is building around the prospects for achieving a usable, fault-tolerant quantum computer, propelled by impressive development progress over the last 12 months. However, in reality, ...
Generative AI (GenAI) has quickly become the technology to watch — one with the potential to overhaul industries. In supply chain management, it holds particular promise for making sense of large vo...
For decades, pharmaceutical industry growth was driven by predictable actions: expanding into new geographies, extending product lifecycles, and optimizing commercial strategies. However, this growth ...
For years, oncology drug launches relied on standardized approaches. But tightening price controls, fiercer competition, and fast-evolving markets are challenging this model. Creating sustainable valu...
